Emory University School of Medicine/Winship Cancer Institute
Atlanta, Georgia 30322
4 studies enrolling now · 13 studies all time
What they study most
Advanced Solid Tumors, Breast Neoplasms, Cancer of Lung, Cancer of the Lung, Carcinoma, Colorectal, Carcinoma, Non-Small-Cell Lung, Cervical Cancer, Chronic Myelogenous Leukemia - Chronic Phase, Colorectal Neoplasms, Endometrial Cancer, Endometrial Neoplasms, Esophageal Neoplasms
Studies at this site
- A Study of LY4257496 in Participants With Cancer (OMNIRAY) — Recruiting now
- Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN — Recruiting now
- An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) — Recruiting now
- CAR-T Long Term Follow Up (LTFU) Study — Recruiting now
- Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation — Running, not enrolling
- PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma — Stopped early
- A Study of WVT078 in Patients With Multiple Myeloma (MM) — Stopped early
- Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia — Running, not enrolling
- Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) — Completed
- Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors — Completed
- Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients — Completed
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC — NO_LONGER_AVAILABLE
- Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies — Completed